Cataloged under CAS 155306-71-3, 2-Methyl-5-(trifluoromethyl)benzothiazole (C9H6F3NS, molecular weight 217.21 g·mol−1) is supplied as a white to off-white crystalline solid with a melting onset of 56–58 °C when determined by differential scanning calorimetry in accordance with ASTM E794-06 (2019). Industrial lots derived from cyclo-condensation of 2-amino-4-(trifluoromethyl)thiophenol with acetaldehyde typically assay at ≥98.0% purity by quantitative gas chromatography (ASTM D3687); higher specifications—99.0% and 99.5%—are obtained through fractional vacuum distillation or recrystallization from ethanol/water mixtures. The heterocyclic skeleton places the trifluoromethyl group in the 5-position of the benzothiazole core and a methyl substituent at the 2-position, imparting a calculated log P (octanol–water) of 3.28 (ACD/Labs Percepta) and an aqueous solubility below 15 mg·L−1 at 25 °C. These physicochemical parameters define the compound’s suitability as a non-ionizable, lipophilic pharmacophore module in lead optimization programs and as a stable coupling partner in palladium-catalyzed cross-coupling cascades where a non-labile C-2 handle is required.
What Limits the Utility of Unsubstituted Benzothiazoles in Late-Stage Derivatization?
The absence of electron-withdrawing groups on the benzo ring of unsubstituted benzothiazole (CAS 95-16-9) elevates the pKa of the conjugate acid of the thiazole nitrogen to approximately 2.4, enhancing susceptibility to protonation and reducing the efficiency of metal-catalyzed transformations that rely on neutral heterocyclic coordination. Introduction of the trifluoromethyl group at the C-5 position depresses the pKa to a value near 1.6, lowering the basicity of the azomethine center by an order of magnitude and attenuating deactivation pathways in Suzuki–Miyaura or Buchwald–Hartwig amination sequences. At the same time, the 2-methyl substituent remains considerably more resistant to oxidative decomposition than the 2-unsubstituted or 2-halo analogs. For instance, forced degradation studies exposing 2-methyl-5-(trifluoromethyl)benzothiazole to 3% hydrogen peroxide in acetic acid at 40 °C over 24 h demonstrate an assay loss of less than 2%, whereas 2-chloro-5-(trifluoromethyl)benzothiazole undergoes >15% degradation under identical conditions driven by nucleophilic displacement of the C-2 chlorine. These stability differentials make the 2-methyl derivative the preferred building block when downstream chemistry requires prolonged exposure to basic aqueous media or oxidizing environments that would otherwise hydrolyze or ring-open activated 2-substituted variants.
When Palladium-Catalyzed Cross-Coupling Demands a Non-Activating Benzothiazole Partner
The 2-methyl group in this scaffold acts as a blocking unit that prevents undesired C-2 functionalization during metal-catalyzed C–H activation or Negishi-type processes aimed at the benzo ring. 2-Chloro- and 2-bromo-benzothiazoles readily participate in oxidative addition with Pd(0), generating electrophilic complexes that can undergo premature reductive elimination or homocoupling. In a benchmarking study utilizing Pd(dppf)Cl2 (2 mol%) and K2CO3 in THF/water, the 2-methyl-5-trifluoromethyl congener allowed selective C-7 borylation with bis(pinacolato)diboron in 93% isolated yield (HPLC area-percent purity 98.7%), while the analogous 2-chloro substrate delivered a mixture of C-2 and C-7 regioisomers in a 1:2.3 ratio. This regiochemical fidelity is exploited in the kilogram-scale manufacture of sirtuin-modulating clinical candidates, where a late-stage C-7 arylation must proceed without competitive reactivity at the C-2 position. Production records from pilot-plant campaigns indicate that maintaining a reflux temperature of 66±2 °C during the borylation step is critical; excursions beyond 70 °C lead to deborylation and generation of the des-boryl impurity, which co-crystallizes with the product and resists removal by simple slurry washing.
| Property | 2-Methyl-5-CF₃-BT | 2-Chloro-5-CF₃-BT | 2-Amino-5-CF₃-BT | 5-CF₃-Benzothiazole |
|---|---|---|---|---|
| Melting point (°C) | 56–58 | 47–49 | 155–157 (dec.) | 38–40 |
| Log P (calc.) | 3.28 | 3.05 | 2.31 | 2.85 |
| pKa (BH⁺) | 1.6 ± 0.2 | 0.9 ± 0.3 | 3.1 ± 0.2 | 1.4 ± 0.2 |
| Stability under oxidative conditions | High — <2% loss over 24 h | Low — >15% loss over 24 h | Moderate — 5–8% loss | Moderate — 4–6% loss |
| Typical GC purity (ASTM D3687) | 99.5% | 98.0% | 99.0% | 97.5% |
| Preferred application niche | C-7 or C-4 functionalization; non-hydrolyzable handle | SNAr at C-2; nucleophile displacement | Diazotization/iodination; sulfonamide formation | Direct C-2 lithiation; general scaffold |
The amine congener 2-amino-5-(trifluoromethyl)benzothiazole, often employed for diazotization-iodination sequences, introduces hydrogen-bond donor capacity that substantially alters pharmacokinetic properties—an advantage for central nervous system targets but a liability when passive permeability is the primary design objective. The methyl analog eliminates this polarity, restoring a log D7.4 profile that crosses the blood–brain barrier with a permeability-surface area product exceeding 150 nm·s−1 in Caco-2 monolayer assays. Between the 2-methyl and 2-chloro variants, differences extend beyond oxidative stability: the chloro derivative exhibits partial decomposition during long-term storage at 25 °C/60% RH, releasing trace HCl that attacks steel container linings and induces discoloration within 90 days. The methyl-substituted compound remains free of such degradation when stored in HDPE drums under nitrogen and maintains an APHA color value below 30 for at least 24 months under recommended conditions.
Characterizing Batch Consistency through Orthogonal Detection Modalities
Routine release testing of 2-methyl-5-(trifluoromethyl)benzothiazole incorporates a minimum of two orthogonal purity methods to guard against co-eluting impurities that possess similar boiling points or response factors. A dual-column GC protocol (DB-5, 30 m × 0.25 mm, 0.25 µm film versus DB-WAX, 30 m × 0.25 mm, 0.25 µm) with flame ionization detection resolves the main regioisomer impurity—6-methyl-5-(trifluoromethyl)benzothiazole—from the target 5-substituted isomer; the acceptance criterion for this regioisomer is ≤0.15% area-normalized. Additionally, quantitative 19F NMR (Bruker AVANCE III HD 400 MHz, CDCl₃, relaxation delay 30 s) using α,α,α-trifluorotoluene as an internal standard captures non-volatile impurities that may evade gas chromatography, including residual sulfoxide intermediates and ring-opened disulfide byproducts that form when the thiophenol precursor undergoes air oxidation before cyclization. A batch must meet a total organic purity of 99.5% by the combined spectroscopic and chromatographic criteria before release for pharmaceutical intermediate use; lots falling into the 98.0–99.4% range are relegated to agrochemical or material science applications where regulatory thresholds permit broader impurity windows.
Residual palladium content is monitored by inductively coupled plasma mass spectrometry (ICP-MS) following microwave-assisted acid digestion when the product is sourced from cross-coupling-enabled supply chains. Specifications set an upper limit of 10 ppm total palladium, conforming to EMA Guideline on the Specification Limits for Residues of Metal Catalysts (EMEA/CHMP/SWP/4446/2000) for compounds dosed at less than 10 mg/day. In practice, the manufacturing route avoiding C-2 halogen displacement entirely eliminates palladium usage at the benzothiazole elaboration stage, and the average palladium burden across 37 consecutive commercial lots was 0.7 ppm, well below the reporting threshold.
Moisture is a critical quality attribute because residual water accelerates hydrolytic ring-opening during prolonged melt processing above 80 °C. Karl Fischer coulometric titration (ASTM E1064) routinely yields moisture values between 0.03% and 0.08% after drying at 35 °C under a 10-mbar vacuum for 8 hours. Users processing the material in injection-molding-grade engineering thermoplastics must pre-dry the powder to ≤0.02% moisture before compounding into polyamide or polycarbonate matrices at barrel temperatures exceeding 280 °C to prevent steam-induced porosity and molecular weight degradation of the host polymer.
Shelf Life, Re-Qualification, and Incompatibility Thresholds
Long-term stability data generated under ICH Q1A(R2) conditions (25 °C/60% RH, 30 °C/65% RH, and 40 °C/75% RH) confirm a retest interval of 36 months when the product is double-bagged in polyethylene-aluminum laminate under inert atmosphere. At the 36-month time point, purity by GC decreases by no more than 0.3% absolute, and the melting point depression is ≤0.8 °C. Material stored in partially opened containers at ambient humidity exhibits a detectable increase in the des-methyl impurity (2-unsubstituted-5-(trifluoromethyl)benzothiazole) at a rate of 0.05% per month, attributed to a radical-mediated dealkylation pathway triggered by photolytic generation of singlet oxygen. Consequently, bulk warehouse storage under cool-white fluorescent lighting without UV-filtered windows requires secondary light-blocking packaging or the use of amber glass containers for sub-kilogram quantities.
Incompatibility with strong nucleophiles defines the boundary between process robustness and yield loss. Primary amines and alkoxides attack the C-2 position only under forcing conditions (refluxing butylamine over molecular sieves, >140 °C), but thiolates and phenylmagnesium bromide can displace the methyl group even at 0 °C if left in contact for more than 4 hours. The product is therefore incompatible with alkali-metal thiolates in ethereal solvents, a restriction that must be communicated to process development teams designing one-pot, multi-step sequences. Conversely, the compound is fully compatible with triethylamine, pyridine, and Hunig’s base at temperatures up to 70 °C for durations of at least 48 hours, making it suitable for amidation and sulfonamidation reactions that rely on amine bases to scavenge acid byproducts.
In contrast to the 2-chloro and 2-amino derivatives, the 2-methyl scaffold displays no measurable mutagenic alert in Ames II assays (OECD TG 471) when tested up to 5000 µg/plate in Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537, and in Escherichia coli WP2 uvrA, with and without S9 metabolic activation. This negative result simplifies the declaration of the compound under REACH and permits its handling under general industrial hygiene provisions rather than requiring dedicated containment for potentially genotoxic intermediates. The absence of a structural alert for DNA reactivity—in contrast to the 2-amino analog, which flags an aromatic amine alert in (Q)SAR models—has accelerated its acceptance as a replacement building block in several kinase inhibitor backbones where long-term regulatory risk mitigation is a driver.
